Ramakrishnan Natesan

5PUBLICATIONS
11CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Polymerisation mechanismsMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 22, 2023
Heterogeneity in Disulfide Bond Reduction in IgG1 Antibodies Is Governed by Solvent Accessibility of the Cysteines.

Ramakrishnan Natesan, Andrew B Dykstra, Akash Banerjee

|Dec 24, 2021
Active Remodeling of Chromatin and Implications for <i>In Vivo</i> Folding.

Ramakrishnan Natesan, Kripa Gowrishankar, Lakshmi Kuttippurathu

|May 05, 2021
Toppling the HAT to Treat Lethal Prostate Cancer.

Reyaz Ur Rasool, Ramakrishnan Natesan, Irfan A Asangani

|Mar 20, 2020
Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression.

Salina Yuan, Ramakrishnan Natesan, Francisco J Sanchez-Rivera

|Aug 31, 2019
CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.

Reyaz Ur Rasool, Ramakrishnan Natesan, Qu Deng

Pageof 1